
Rabemint D 30mg/20mg Capsule SR
Marketer
Mint Life Sciences Pvt Ltd
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rabemint D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with Rabemint D 30mg/20mg sustained-release capsules, a dual-action formulation. This medication alleviates common GERD symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Rabemint D should be taken on an empty stomach, following your physician's prescribed dosage and schedule. Treatment duration depends on individual response and the severity of your condition; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete transparency with your healthcare provider regarding all other medications is crucial, as interactions may occur. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding stimulants like coffee, tea, spicy food, and chocolate, may enhance treatment outcomes. Prior to commencing Rabemint D, disclose any pre-existing liver or kidney conditions, as well as pregnancy, pregnancy plans, or breastfeeding.
Uses of Rabemint D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabemint D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Rabemint D 30mg/20mg SR capsules on an empty stomach.
Common Side effects of Rabemint D 30mg/20mg Capsule SR:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Rabemint D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire capsule; avoid chewing, crushing, or breaking it. Administer Rabemint D 30mg/20mg Sustained-Release capsules on an empty stomach.
How Rabemint D 30mg/20mg Capsule SR works:
Rabeprazole and Domperidone 30mg/20mg sustained-release capsules (Rabemint D) combine two active ingredients to manage digestive discomfort. Rabeprazole, a proton pump inhibitor (PPI), lessens stomach acid production, easing heartburn and acid indigestion. Domperidone, a prokinetic agent, enhances the motility of the upper gastrointestinal tract, facilitating smoother food passage through the stomach.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rabemint D 30mg/20mg SR capsules with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rabemint D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Rabemint D 30mg/20mg sustained-release capsules while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rabemint D 30mg/20mg sustained-release capsules may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Rabemint D 30mg/20mg sustained-release capsules cautiously. Dosage modification of Rabemint D 30mg/20mg sustained-release capsules may be necessary; physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Rabemint D 30mg/20mg SR capsules; dosage modification may be necessary. Consult a physician for guidance. Rabemint D 30mg/20mg SR capsules are unsuitable for patients experiencing moderate to severe hepatic dysfunction.
What if you forget to take Rabemint D 30mg/20mg Capsule SR :
Should you forget to take a Rabemint D 30mg/20mg sustained-release capsule, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabemint D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
